What Remicade treats.
- Rheumatoid arthritis
- Crohn’s disease
- Ulcerative colitis
- Ankylosing spondylitis
- Psoriatic arthritis
- Plaque psoriasis
The mechanism.
Remicade (infliximab) is a TNF-alpha inhibitor — a monoclonal antibody that blocks tumor necrosis factor, a protein that drives inflammation in many autoimmune conditions. By neutralizing TNF, Remicade reduces inflammation, prevents tissue damage, and allows your body to heal.
Your Remicade infusion experience.
Remicade infusions typically take 2 to 3 hours. After an initial loading schedule (week 0, 2, and 6), most patients move to maintenance dosing every 6 to 8 weeks. We monitor vital signs throughout each session, and your first few infusions may include pre-medications such as antihistamines or steroids to reduce reaction risk.
Insurance & out-of-pocket cost.
Remicade is covered by most commercial insurance and Medicare Part B when prescribed by your physician for an FDA-approved indication. We verify your benefits before your first infusion and handle prior authorization on your behalf. Most commercially insured patients pay only their standard specialty copay — typically $20–$100 per visit. Manufacturer copay assistance programs may further reduce your cost.